© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

Oxford Covid vaccine 10% effective against South African variant, study suggests

Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection

  • Coronavirus – latest updates
  • See all our coronavirus coverage

The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have suggested.

Scientists who conducted a small-scale trial of the vaccine’s efficacy said it showed very little protection against mild to moderate infection, though they expressed hope that – in theory – it would still offer significant protection against more serious infection.

Continue reading…

Related posts

Six-year-old twins go missing from their garden in south London

AEA3

Concerns grow for children’s health as screen times soar during Covid crisis

AEA3

Energy use is a ‘decision for individuals’ insist No 10 and Truss allies

AEA3

Pin It on Pinterest

Share This